We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLloyds Regulatory News (LLOY)

Share Price Information for Lloyds (LLOY)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 52.52
Bid: 52.50
Ask: 52.54
Change: 0.22 (0.42%)
Spread: 0.04 (0.076%)
Open: 52.68
High: 52.82
Low: 52.32
Prev. Close: 52.30
LLOY Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Publication of Suppl.Prospcts

27 Apr 2017 17:28

RNS Number : 6162D
Lloyds Banking Group PLC
27 April 2017
 

27 April 2017

 

Publication of Supplementary Prospectus

The following Supplementary Prospectus has been approved by the UK Listing Authority and is available for viewing:

Supplementary Prospectus dated 27 April 2017 (the "Supplementary Prospectus") relating to the £25,000,000,000 Euro Medium Term Note Programme of Lloyds Banking Group plc.

The Supplementary Prospectus should be read and construed in conjunction with the base prospectus dated 30 March 2017 (the "Base Prospectus").

To view the Supplementary Prospectus, please paste the following URL into the address bar of your browser:

http://www.rns-pdf.londonstockexchange.com/rns/6162D_-2017-4-27.pdf

The Supplementary Prospectus has been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.Hemscott.com/nsm.do.

For further information, please contact:

Investor Relations:

 

Douglas RadcliffeGroup Investor Relations Director 

Tel: +44 20 7356 1571

Email: douglas.radcliffe@finance.lloydsbanking.com

 

Corporate Affairs:

 

Matt Smith

Head of Corporate Media

Tel: +44 20 7356 3522

E-mail: matt.smith@lloydsbanking.com

 

Lloyds Banking Group plcRegistered OfficeThe MoundEdinburghEH1 1YZ

 

DISCLAIMER - INTENDED ADDRESSEES

Please note that the information contained in this announcement and the Supplementary Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Base Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries and/or to whom this announcement and the Supplementary Prospectus are not addressed. Prior to relying on the information contained in this announcement and the Supplementary Prospectus, you must ascertain from the Base Prospectus whether or not you are one of the intended addressees of the information contained in this announcement and the Supplementary Prospectus.

In particular, this announcement and the Supplementary Prospectus do not constitute an offer or invitation to subscribe for, or purchase, securities in the United States or in any other jurisdiction where such an offer or invitation would be unlawful. This announcement and the Supplementary Prospectus are not for distribution in the United States. The securities described herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. Subject to certain exceptions, the securities may not be offered or sold within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America, as such terms are defined in Regulation S under the Securities Act. There will be no public offering of the securities in the United States. For a description of the restrictions on offers and sales of the securities described herein, please refer to the Supplementary Prospectus and Base Prospectus.

Your right to access this service is conditional upon complying with the above requirement.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PSPEAKLXAASXEFF
Date   Source Headline
25th Oct 20237:00 amRNS2023 Q3 Interim Management Statement
11th Oct 20232:00 pmRNSDirector/PDMR Shareholding
22nd Sep 20232:00 pmRNSDirector/PDMR Shareholding
21st Sep 20231:28 pmRNSPublication of Final Terms
20th Sep 20232:00 pmRNSDirector/PDMR Shareholding
15th Sep 20232:00 pmRNSDirector/PDMR Shareholding
13th Sep 20232:00 pmRNSBoard and Committee changes
13th Sep 20231:45 pmRNSDirector/PDMR Shareholding
13th Sep 20239:20 amRNS2023 Half-Year Results
31st Aug 202312:00 pmRNSTotal Voting Rights
29th Aug 20237:21 amRNSCompletion of £2 billion Share Buyback Programme
25th Aug 20235:51 pmRNSTransaction in Own Shares
24th Aug 20235:38 pmRNSTransaction in Own Shares
24th Aug 20235:30 pmRNSTotal Voting Rights
23rd Aug 20235:21 pmRNSTransaction in Own Shares
22nd Aug 20235:18 pmRNSTransaction in Own Shares
22nd Aug 202311:44 amRNSPublication of Pricing Supplement
22nd Aug 20239:39 amRNSStabilisation Notice
21st Aug 20235:14 pmRNSTransaction in Own Shares
18th Aug 20235:37 pmRNSTransaction in Own Shares
17th Aug 20235:39 pmRNSTransaction in Own Shares
16th Aug 20235:29 pmRNSTransaction in Own Shares
15th Aug 20235:28 pmRNSTransaction in Own Shares
14th Aug 20235:36 pmRNSTransaction in Own Shares
11th Aug 20235:49 pmRNSTransaction in Own Shares
10th Aug 20235:42 pmRNSTransaction in Own Shares
10th Aug 20232:00 pmRNSDirector/PDMR Shareholding
9th Aug 20235:41 pmRNSTransaction in Own Shares
8th Aug 20235:29 pmRNSTransaction in Own Shares
7th Aug 20236:04 pmRNSTransaction in Own Shares
4th Aug 20235:19 pmRNSTransaction in Own Shares
3rd Aug 20235:28 pmRNSTransaction in Own Shares
31st Jul 20235:36 pmRNSTransaction in Own Shares
31st Jul 20234:00 pmRNSDirector/PDMR Shareholding
31st Jul 202312:00 pmRNSTotal Voting Rights
27th Jul 202310:00 amRNSDirector Declaration
26th Jul 20235:33 pmRNSTransaction in Own Shares
26th Jul 202312:18 pmRNSPublication of Suppl.Prospcts
26th Jul 202311:57 amRNS2023 Half-Year Results
26th Jul 202311:56 amRNS2023 Half-Year Results
26th Jul 20237:00 amRNS2023 Half-Year Results - Part 2 of 2
26th Jul 20237:00 amRNS2023 Half-Year Results - Part 1 of 2
14th Jul 20235:23 pmRNSTransaction in Own Shares
13th Jul 20235:26 pmRNSTransaction in Own Shares
12th Jul 20235:38 pmRNSTransaction in Own Shares
12th Jul 20234:45 pmRNSDirector/PDMR Shareholding
12th Jul 20237:13 amRNSBOE STRESS TEST PASSED
11th Jul 20235:33 pmRNSTransaction in Own Shares
10th Jul 20235:41 pmRNSTransaction in Own Shares
10th Jul 202310:49 amRNSNotice of Redemption

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.